Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Detection of differentially expressed genes in human colon carcinoma cells treated with a selective COX-2 inhibitor

Oncogene volume 20, pages 4450–4456 (2001)Cite this article

Abstract

Numerous reports suggest that use of nonsteroidal anti-inflammatory drugs (NSAIDs) decrease mortality from colorectal cancer. To better understand all of the mechanisms underlying this effect, the global pattern of gene expression in colon carcinoma cells following treatment with NS-398, a selective cyclo-oxygenase-2 inhibitor was evaluated. We utilized suppression subtractive hybridization combined with differential screening to identify genes whose expression was affected following treatment. Among the subtracted cDNA fragments confirmed as differentially expressed, there were two which are known to be involved in the regulation of cell adhesion (human FAT and proto-cadherin-7). We identified two other genes whose levels were decreased and these are known to be involved in the regulation of cell proliferation (cyclin K and p-100). We identified additional genes which are involved in different signaling pathways which regulate programmed cell death (Dynamin 2, Pdcd4 and LIP.1). These results provide evidence that some of the effects of NS-398 on carcinoma cells may be due to modulation of genes which regulate programmed cell death, cell proliferation and cell–cell communication. Additional studies are underway to determine the biological function of the novel genes that were identified.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  • Akopian AN, Wood JN . 1995 J. Biol. Chem. 270: 21264–21270

  • Chang YW, Jakobi R, McGinty A, Foschi M, Dunn MJ, Sorokin A . 2000 Mol. Cell. Biol. 20: 8571–8579

  • Cmarik JL, Min H, Hegamyer G, Zhan S, Kulesz-Martin M, Yoshinaga H, Matsuhashi S, Colburn NH . 1999 Proc. Natl. Acad. Sci. USA 96: 14037–14042

  • Deleersnijder W, Hong G, Cortvrindt R, Poirier C, Tylzanowski P, Pittois K, Van Marck E, Merregaert J . 1996 J. Biol. Chem. 271: 19475–19482

  • Diatchenko L, Lau YF, Campbell AP, Chenchik A, Moqadam F, Huang B, Lukyanov S, Lukyanov K, Gurskaya N, Sverdlov ED, Siebert PD . 1996 Proc. Natl. Acad. Sci. USA 93: 6025–6030

  • Drmanac R, Drmanac S . 1999 Methods Enzymol. 303: 165–178

  • DuBois RN, Radhika A, Reddy BS, Entingh AJ . 1996 Gastroenterology 110: 1259–1262

  • Dunne J, Hanby AM, Poulsom R, Jones TA, Sheer D, Chin WG, Da SM, Zhao Q, Beverley PC, Owen MJ . 1995 Genomics 30: 207–223

  • Eberhart CE, Coffey RJ, Radhika A, Giardiello FM, Ferrenbach S, DuBois RN . 1994 Gastroenterology 107: 1183–1188

  • Edwards MC, Wong C, Elledge SJ . 1998 Mol. Cell. Biol. 18: 4291–4300

  • Fish KN, Schmid SL, Damke H . 2000 J. Cell. Biol. 150: 145–154

  • Hanif R, Pittas A, Feng Y, Koutsos MI, Qiao L, Staiano-Coico L, Shiff SI, Rigas B . 1996 Biochem. Pharmacol. 52: 237–245

  • Hara A, Yoshimi N, Niwa M, Ino N, Mori H . 1997 Jpn. J. Cancer Res. 88: 600–604

  • He TC, Chan TA, Vogelstein B, Kinzler KW . 1999 Cell 99: 335–345

  • Heidebrecht HJ, Buck F, Steinmann J, Sprenger R, Wacker HH, Parwaresch R . 1997 Blood 90: 226–233

  • Jacoby RF, Seibert K, Cole CE, Kelloff G, Lubet RA . 2000 Cancer Res. 60: 5040–5044

  • Jones MK, Wang H, Peskar BM, Levin E, Itani RM, Sarfeh IJ, Tarnawski AS . 1999 Nat. Med. 5: 1418–1423

  • Kinoshita T, Takahashi Y, Sakashita T, Inoue H, Tanabe T, Yoshimoto T . 1999 Biochim. Biophys. Acta 1438: 120–130

  • Kopp E, Ghosh S . 1994 Science 265: 956–959

  • Kuang WW, Thompson DA, Hoch RV, Weigel RJ . 1998 Nucleic Acids Res. 26: 1116–1123

  • Kuroda S, Tokunaga C, Kiyohara Y, Higuchi O, Konishi H, Mizuno K, Gill GN, Kikkawa U . 1996 J. Biol. Chem. 271: 31029–31032

  • Landis SH, Murray T, Bolden S, Wingo PA . 1999 CA Cancer J. Clin. 49: 8–31

  • Lehmann JM, Lenhard JM, Oliver BB, Ringold GM, Kliewer SA . 1997 J. Biol. Chem. 272: 3406–3410

  • Liang P, Pardee AB . 1992 Science 257: 967–971

  • Lisitsyn N, Lisitsyn N, Wigler M . 1993 Science 259: 946–951

  • Liu XH, Kirschenbaum A, Yao S, Lee R, Holland JF, Levine AC . 2000 J. Urol. 164: 820–825

  • Liu XH, Yao S, Kirschenbaum A, Levine AC . 1998 Cancer Res. 58: 4245–4249

  • Mahoney PA, Weber U, Onofrechuk P, Biessmann H, Bryant PJ, Goodman CS . 1991 Cell 67: 853–868

  • Maser RL, Calvet JP . 1995 Semin. Nephrol. 15: 29–42

  • McGinty A, Chang YW, Sorokin A, Bokemeyer D, Dunn MJ . 2000 J. Biol. Chem. 275: 12095–12101

  • Nagase T, Miyajima N, Tanaka A, Sazuka T, Seki N, Sato S, Tabata S, Ishikawa K, Kawarabayasi Y, Kotani H. et al . 1995 DNA Res. 2: 51–59

  • Nakagawa N, Hoshijima M, Oyasu M, Saito N, Tanizawa K, Kuroda S . 2000 Biochem. Biophys. Res. Commun. 272: 505–512

  • Nishimura G, Yanoma S, Mizuno H, Kawakami K, Tsukuda M . 1999 Jpn. J. Cancer Res. 90: 1152–1162

  • Oshima M, Dinchuk JE, Kargman SL, Oshima H, Hancock B, Kwong E, Trzaskos JM, Evans JF, Taketo MM . 1996 Cell 87: 803–809

  • Rioux N, Castonguay A . 1998 Cancer Res. 58: 5354–5360

  • Sawaoka H, Kawano S, Tsuji S, Tsujii M, Gunawan ES, Takei Y, Nagano K, Hori M . 1998 Am. J. Physiol. 274: G1061–G1067

  • Serra-Pages C, Kedersha NL, Fazikas L, Medley Q, Debant A, Streuli M . 1995 EMBO J. 14: 2827–2838

  • Sheng H, Shao J, Kirkland SC, Isakson P, Coffey RJ, Morrow J, Beauchamp RD, DuBois RN . 1997 J. Clin. Invest. 99: 2254–2259

  • Shibahara K, Asano M, Ishida Y, Aoki T, Koike T, Honjo T . 1995 Gene 166: 297–301

  • Shureiqi I, Chen D, Lee JJ, Yang P, Newman RA, Brenner DE, Lotan R, Fischer SM, Lippman SM . 2000 J. Natl. Cancer. Inst. 92: 1136–1142

  • Smith M, Hawcroft G, Hull MA . 2000 Eur. J. Cancer 36: 664–674

  • Thun MJ, Namboodiri MM, Heath Jr CW . 1991 N. Engl. J. Med. 325: 1593–1596

  • Tsuji S, Kawano S, Sawaoka H, Takei Y, Kobayashi I, Nagano K, Fusamoto H, Kamada T . 1996 Prostagland. Leukot. Essent. Fatty Acids 55: 179–183

  • Tsujii M, DuBois RN . 1995 Cell 83: 493–501

  • Tsujii M, Kawano S, DuBois RN . 1997 Proc. Natl. Acad. Sci. USA 94: 3336–3340

  • Tsujii M, Kawano S, Tsuji S, Sawaoka H, Hori M, DuBois RN . 1998 Cell 93: 705–716

  • von Stein OD, Thies WG, Hofmann M . 1997 Nucleic Acids Res. 25: 2598–2602

  • Wang X, Weng LP, Yu Q . 2000 Oncogene 19: 2346–2353

  • Watanabe K, Kawamori T, Nakatsugi S, Ohta T, Ohuchida S, Yamamoto H, Maruyama T, Kondo K, Ushikubi F, Narumiya S, Sugimura T, Wakabayashi K . 1999 Cancer Res. 59: 5093–5096

  • Wechter WJ, Kantoci D, Murray Jr ED, Quiggle DD, Leipold DD, Gibson KM, McCracken JD . 1997 Cancer Res. 57: 4316–4324

  • Weng LP, Wang X, Yu Q . 1999 Genes Cells 4: 185–196

  • Williams CS, Luongo C, Radhika A, Zhang T, Lamps LW, Nanney LB, Beauchamp RD, DuBois RN . 1996 Gastroenterology 111: 1134–1140

  • Williams CS, Tsujii M, Reese J, Dey SK, DuBois RN . 2000a J. Clin. Invest. 105: 1589–1594

  • Williams CS, Watson AJ, Sheng H, Helou R, Shao J, DuBois RN . 2000b Cancer Res. 60: 6045–6051

  • Yin MJ, Yamamoto Y, Gaynor RB . 1998 Nature 396: 77–80

  • Yoshida K, Yoshitomo-Nakagawa K, Seki N, Sasaki M, Sugano S . 1998 Genomics 49: 458–461

  • Yoshimi N, Shimizu M, Matsunaga K, Yamada Y, Fujii K, Hara A, Mori H . 1999 Jpn J. Cancer Res. 90: 406–412

  • Zeng J, Gorski RA, Hamer D . 1994 Nucleic Acids Res. 22: 4381–4385

  • Zhang X, Morham SG, Langenbach R, Young DA . 1999 J. Exp. Med. 190: 451–459

  • Zuber J, Tchernitsa OI, Hinzmann B, Schmitz AC, Grips M, Hellriegel M, Sers C, Rosenthal A, Schafer R . 2000 Nat. Genet. 24: 144–152

Download references

Acknowledgements

This work was supported in part from the United States Public Health Services Grants DK47297 (RN Dubois), P0 CA77839 (RN Dubois), P30 CA68485 (RN Dubois). RN Dubois is a recipient of a Veterans Affairs Research Merit Grant. We acknowledge the TJ Martell Foundation and the NCCRA for their generous support.

Author information

Authors and Affiliations

  1. Department of Medicine, Vanderbilt University Medical Center, Nashville, 37232-2279, Tennessee, TN, USA

    Zhonghua Zhang & Raymond N DuBois

  2. Department of Cell Biology, Vanderbilt University Medical Center, Nashville, 37232-2279, Tennessee, TN, USA

    Raymond N DuBois

  3. Department of Veterans Affairs Medical Center, Nashville, 37232-2279, Tennessee, TN, USA

    Raymond N DuBois

Authors
  1. Zhonghua Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Raymond N DuBois
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Raymond N DuBois.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zhang, Z., DuBois, R. Detection of differentially expressed genes in human colon carcinoma cells treated with a selective COX-2 inhibitor. Oncogene 20, 4450–4456 (2001). https://doi.org/10.1038/sj.onc.1204588

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1204588

Keywords

This article is cited by

Search

Advanced search

Quick links